BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 19267156)

  • 21. Elevated p21 expression is associated with poor prognosis of rectal stromal tumors after resection.
    Hu TH; Tai MH; Chuah SK; Chen HH; Lin JW; Huang HY; Chou YP; Yi LN; Kuo CM; Changchien CS
    J Surg Oncol; 2008 Aug; 98(2):117-23. PubMed ID: 18521824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of outcome of open and laparoscopic resection for stage II and stage III rectal cancer.
    Law WL; Poon JT; Fan JK; Lo SH
    Ann Surg Oncol; 2009 Jun; 16(6):1488-93. PubMed ID: 19290491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Proliferating cell nuclear antigen (PCNA) in ovarian carcinoma and its relation to lymph node metastasis and prognosis].
    Wu X; Zhang Z; Cai S
    Zhonghua Zhong Liu Za Zhi; 1998 Jan; 20(1):68-70. PubMed ID: 10921065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of vascular endothelial growth factor and cyclooxygenase-2 in patients with rectal cancer treated with preoperative radiotherapy.
    Giralt J; Navalpotro B; Hermosilla E; de Torres I; Espin E; Reyes V; Cerezo L; de las Heras M; Ramon y Cajal S; Armengol M; Benavente S
    Oncology; 2006; 71(5-6):312-9. PubMed ID: 17687192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer.
    Kim JC; Takahashi K; Yu CS; Kim HC; Kim TW; Ryu MH; Kim JH; Mori T
    Ann Surg; 2007 Nov; 246(5):754-62. PubMed ID: 17968166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metastatic lymph node ratio in stage III rectal carcinoma is a valuable prognostic factor even with less than 12 lymph nodes retrieved: a prospective study.
    Madbouly KM; Abbas KS; Hussein AM
    Am J Surg; 2014 Jun; 207(6):824-31. PubMed ID: 24112666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lateral pelvic lymph node dissection for advanced lower rectal cancer.
    Fujita S; Yamamoto S; Akasu T; Moriya Y
    Br J Surg; 2003 Dec; 90(12):1580-5. PubMed ID: 14648739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcome after curative resection for locally recurrent rectal cancer.
    Bedrosian I; Giacco G; Pederson L; Rodriguez-Bigas MA; Feig B; Hunt KK; Ellis L; Curley SA; Vauthey JN; Delclos M; Crane CH; Janjan N; Skibber JM
    Dis Colon Rectum; 2006 Feb; 49(2):175-82. PubMed ID: 16392024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do proliferating cell nuclear antigen and MIB-1/Ki-67 have prognostic value in penile squamous cell carcinoma?
    GuimarĂ£es GC; Leal ML; Campos RS; Zequi Sde C; da Fonseca FP; da Cunha IW; Soares FA; Lopes A
    Urology; 2007 Jul; 70(1):137-42. PubMed ID: 17656224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Impact of mesorectal involvement on the outcome of patients with rectal cancer].
    Li L; Chen ZR; Zhang Y; Wang XD; Shu Y; Zhou ZG; Li K
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):295-7. PubMed ID: 16608099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
    Bertolini F; Bengala C; Losi L; Pagano M; Iachetta F; Dealis C; Jovic G; Depenni R; Zironi S; Falchi AM; Luppi G; Conte PF
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1455-61. PubMed ID: 17445998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of different biological markers (DNA index, PCNA index, apoptosis, p53, karyotype) in 126 adenocarcinoma gastric biopsies.
    Matturri L; Biondo B; Cazzullo A; Colombo B; Giordano F; Guarino M; Pallotti F; Turconi P; Lavezzi AM
    Anticancer Res; 1998; 18(4B):2819-25. PubMed ID: 9713468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Relationship between insulin-like growth factor II and prognosis of colorectal cancer].
    Xu Z; Liu F; Qi X; Li J
    Zhonghua Wai Ke Za Zhi; 1999 Dec; 37(12):718-20, 43. PubMed ID: 11829934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of para-aortic lymphadenectomy in surgical management of patients with stage N+ rectal cancer below the peritoneal reflection.
    Liu YL; Wang YH; Yang YM; Li MQ; Jiang SX; Wang XS
    Cell Biochem Biophys; 2012 Jan; 62(1):41-6. PubMed ID: 21833674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression and clinical significance of IGF-II mRNA and bcl-2 protein in colorectal adenocarcinomas].
    Zhang MS; Yuan HY; Xiong B; Deng Q; Tang ZJ; Xia D
    Ai Zheng; 2002 Nov; 21(11):1226-30. PubMed ID: 12526221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pelvic exenteration for clinical T4 rectal cancer: oncologic outcome in 93 patients at a single institution over a 30-year period.
    Ishiguro S; Akasu T; Fujita S; Yamamoto S; Kusters M; Moriya Y
    Surgery; 2009 Feb; 145(2):189-95. PubMed ID: 19167974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of circumferential resection margin following total mesorectal excision and adjuvant chemoradiotherapy in patients with rectal cancer.
    Baik SH; Kim NK; Lee YC; Kim H; Lee KY; Sohn SK; Cho CH
    Ann Surg Oncol; 2007 Feb; 14(2):462-9. PubMed ID: 17096053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Correlation of invasion, metastasis, and prognosis in low and middle rectal cancer].
    He WJ; Wang L; Hu H; Kang SY; Qian HX; Xu FM
    Ai Zheng; 2002 Nov; 21(11):1222-5. PubMed ID: 12526220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gelatinase B expression as a prognostic factor in patients with stage II/III rectal carcinoma treated by postoperative adjuvant therapy.
    Unsal D; Akyurek N; Uner A; Erpolat OP; Han U; Akmansu M; Mentes BB; Dursun A
    Am J Clin Oncol; 2008 Feb; 31(1):55-63. PubMed ID: 18376229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of cyclin E isoforms correlates with poor prognosis in rectal cancer.
    Zhou YJ; Xie YT; Gu J; Yan L; Guan GX; Liu X
    Eur J Surg Oncol; 2011 Dec; 37(12):1078-84. PubMed ID: 21944050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.